Vladan has a PhD in molecular medicine from the University of Turin, Italy, where he investigated the potential role of malignant pleural mesotheliomastem cells in the development of the chemo resistant and immuneresistant phenotype of this highly aggressive tumor. He is currently a researcher in the Östman and Akslen groups, aiming to identify novel biomarkers and therapeutic targets of aggressive breast cancer through high-multiplex profiling of the tumor microenvironment using the Hyperion Imaging Mass Cytometry platform.

CCBIO901

CCBIO905

Academic article

• Røgenes, Hanna; Finne, Kenneth; Winge, Ingeborg et al. (2024). Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry. (external link)
• Milosevic, Vladan; Edelmann, Reidunn Jetne; Winge, Ingeborg et al. (2023). Vessel size as a marker of survival in estrogen receptor positive breast cancer. (external link)

Academic literature review

• Milosevic, Vladan; Östman, Arne (2024). Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential. (external link)
• Milosevic, Vladan (2023). Different approaches to Imaging Mass Cytometry data analysis. (external link)
• Milosevic, Vladan (2023). Different approaches to Imaging Mass Cytometry data analysis. (external link)

Academic chapter/article/Conference paper

• Milosevic, Vladan; Edelmann, Reidunn Jetne; Fosse, Johanna Hol et al. (2022). Molecular Phenotypes of Endothelial Cells in Malignant Tumors. (external link)

See a complete overview of publications in Cristin.

Vladan Milosevic, Different approaches to Imaging Mass Cytometry data analysis, Bioinformatics Advances, Volume 3, Issue 1, 2023, vbad046, https://doi.org/10.1093/bioadv/vbad046